Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SEATTLE GENETICS INC /WA | 72,556 | reported | 29 Nov 2018 | tx 73+339,451−159,122 |
| Pyxis Oncology, Inc. | 45,867 | reported | 24 Mar 2026 | tx 7+376,442 |
| Xenon Pharmaceuticals Inc. | 40,000 | reported | 09 Jan 2026 | tx 3+245,800 |
| PLIANT THERAPEUTICS, INC. | 30,000 | reported | 05 Jun 2025 | tx 4+92,764 |
| IMPEL NEUROPHARMA INC | 13,222 | reported | 16 Jun 2023 | tx 2+33,235 |
| STEMLINE THERAPEUTICS INC | 0 | reported | 10 Jun 2020 | tx 3+35,468−35,468 |
| GW PHARMACEUTICALS PLC | 0 | reported | 05 May 2021 | tx 20+718,152−592,632 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | GRANT_AWARD | Pyxis Oncology, Inc. | 45,867 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 20,000 | 0.00 USD | deriv |
| 09 Jan 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 185,800 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | Pyxis Oncology, Inc. | 36,979 | 0.98 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 26,764 | 0.00 USD | deriv |
| 26 Mar 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 35,219 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 13,222 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 14,000 | 0.00 USD | deriv |
| 12 Apr 2023 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 20,013 | 0.00 USD | deriv |
| 24 Mar 2023 | GRANT_AWARD | Pyxis Oncology, Inc. | 139,355 | 0.00 USD | |
| 06 Mar 2023 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 22,000 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | Pyxis Oncology, Inc. | 66,831 | 0.00 USD | |
| 08 Dec 2021 | PURCHASE | Pyxis Oncology, Inc. | 10,000 | 9.39 USD | |
| 07 Oct 2021 | GRANT_AWARD | Pyxis Oncology, Inc. | 42,191 | 0.00 USD | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 5,556 | — | |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 46,896 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 177,180 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 106,320 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 22,068 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 54,192 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 98,040 | — | deriv |
| 05 May 2021 | OTHER | GW PHARMACEUTICALS PLC | 75,024 | — | deriv |
| 02 Mar 2021 | GRANT_AWARD | GW PHARMACEUTICALS PLC | 46,896 | 0.00 USD | deriv |